181 related articles for article (PubMed ID: 32896077)
1. Meta-analysis: Association between hepatitis B virus preS mutation and hepatocellular carcinoma risk.
Wungu CDK; Ariyanto FC; Prabowo GI; Soetjipto S; Handajani R
J Viral Hepat; 2021 Jan; 28(1):61-71. PubMed ID: 32896077
[TBL] [Abstract][Full Text] [Related]
2. Clinical Implications of HBV PreS/S Mutations and the Effects of PreS2 Deletion on Mitochondria, Liver Fibrosis, and Cancer Development.
Liang YJ; Teng W; Chen CL; Sun CP; Teng RD; Huang YH; Liang KH; Chen YW; Lin CC; Su CW; Tao MH; Wu JC
Hepatology; 2021 Aug; 74(2):641-655. PubMed ID: 33675094
[TBL] [Abstract][Full Text] [Related]
3. PreS deletion profiles of hepatitis B virus (HBV) are associated with clinical presentations of chronic HBV infection.
Li X; Qin Y; Liu Y; Li F; Liao H; Lu S; Qiao Y; Xu D; Li J
J Clin Virol; 2016 Sep; 82():27-32. PubMed ID: 27415434
[TBL] [Abstract][Full Text] [Related]
4. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.
Liu S; Zhang H; Gu C; Yin J; He Y; Xie J; Cao G
J Natl Cancer Inst; 2009 Aug; 101(15):1066-82. PubMed ID: 19574418
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment.
Gil-García AI; Madejón A; Francisco-Recuero I; López-López A; Villafranca E; Romero M; García A; Olveira A; Mena R; Larrubia JR; García-Samaniego J
World J Gastroenterol; 2019 Oct; 25(38):5883-5896. PubMed ID: 31636479
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the HBV PreS/S gene related to hepatocellular carcinoma in Vietnamese chronic HBV-infected patients.
Thi Cam Huong N; Trung NQ; Luong BA; Tram DB; Vu HA; Bui HH; Pham Thi Le H
PLoS One; 2022; 17(4):e0266134. PubMed ID: 35390033
[TBL] [Abstract][Full Text] [Related]
7. Association of novel mutations and haplotypes in the preS region of hepatitis B virus with hepatocellular carcinoma.
Xie JX; Zhao J; Yin JH; Zhang Q; Pu R; Lu WY; Zhang HW; Wang HY; Cao GW
Front Med China; 2010 Dec; 4(4):419-29. PubMed ID: 21104161
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus subgenotype A1 predominates in liver disease patients from Kerala, India.
Gopalakrishnan D; Keyter M; Shenoy KT; Leena KB; Thayumanavan L; Thomas V; Vinayakumar K; Panackel C; Korah AT; Nair R; Kramvis A
World J Gastroenterol; 2013 Dec; 19(48):9294-306. PubMed ID: 24409056
[TBL] [Abstract][Full Text] [Related]
9. Significant association of different preS mutations with hepatitis B-related cirrhosis or hepatocellular carcinoma.
Yin J; Xie J; Zhang H; Shen Q; Han L; Lu W; Han Y; Li C; Ni W; Wang H; Cao G
J Gastroenterol; 2010 Oct; 45(10):1063-71. PubMed ID: 20419326
[TBL] [Abstract][Full Text] [Related]
10. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
[TBL] [Abstract][Full Text] [Related]
11. Mutations in preS genes of genotype C hepatitis B virus in patients with chronic hepatitis B and hepatocellular carcinoma.
Gao ZY; Li T; Wang J; Du JM; Li YJ; Li J; Lu FM; Zhuang H
J Gastroenterol; 2007 Sep; 42(9):761-8. PubMed ID: 17876546
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of Hepatitis B virus sub-genotypes and incidence of preS1/preS2 region mutations in HBV-infected Egyptian patients from Mansoura.
El-Mowafy M; Elgaml A; El-Mesery M; Elegezy M
J Med Virol; 2017 Sep; 89(9):1559-1566. PubMed ID: 28390175
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of hepatitis B virus isolated from Black South African cancer patients, with and without hepatocellular carcinoma.
Mak D; Kramvis A
Arch Virol; 2020 Aug; 165(8):1815-1825. PubMed ID: 32504396
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of hepatitis B virus preS deletions occurring naturally in Korean patients infected chronically with genotype C.
Mun HS; Lee SA; Jee Y; Kim H; Park JH; Song BC; Yoon JH; Kim YJ; Lee HS; Hyun JW; Hwang ES; Kook YH; Kim BJ
J Med Virol; 2008 Jul; 80(7):1189-94. PubMed ID: 18461612
[TBL] [Abstract][Full Text] [Related]
15. Applications of human hepatitis B virus preS domain in bio- and nanotechnology.
Toita R; Kawano T; Kang JH; Murata M
World J Gastroenterol; 2015 Jun; 21(24):7400-11. PubMed ID: 26139986
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Novel Hepatitis B Virus PreS/S-Gene Mutations in a Patient with Occult Hepatitis B Virus Infection.
Chen J; Liu Y; Zhao J; Xu Z; Chen R; Si L; Lu S; Li X; Wang S; Zhang K; Li J; Han J; Xu D
PLoS One; 2016; 11(5):e0155654. PubMed ID: 27182775
[TBL] [Abstract][Full Text] [Related]
17. Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases.
Raimondo G; Costantino L; Caccamo G; Pollicino T; Squadrito G; Cacciola I; Brancatelli S
J Hepatol; 2004 Mar; 40(3):515-9. PubMed ID: 15123368
[TBL] [Abstract][Full Text] [Related]
18. Whole genome HBV deletion profiles and the accumulation of preS deletion mutant during antiviral treatment.
Zhang D; Dong P; Zhang K; Deng L; Bach C; Chen W; Li F; Protzer U; Ding H; Zeng C
BMC Microbiol; 2012 Dec; 12():307. PubMed ID: 23272650
[TBL] [Abstract][Full Text] [Related]
19. A matched case-control study of hepatitis B virus mutations in the preS and core promoter regions associated independently with hepatocellular carcinoma.
Liu S; Xie J; Yin J; Zhang H; Zhang Q; Pu R; Li C; Ni W; Wang H; Cao G
J Med Virol; 2011 Jan; 83(1):45-53. PubMed ID: 21108338
[TBL] [Abstract][Full Text] [Related]
20. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
